T. Rowe Price Health Sciences Fund (PRHSX)
Ticker Symbol:
PRHSX
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 1, 2015 at 4pm EST
Fund Composition
Asset Allocation
as of 06/30/2015
Volatility and Other Measures
as of 07/31/2015
Beta 0.85
0.30
Standard Deviation 13.06
Price/Earnings Ratio (Domestic) 20.7
Earnings Growth Rate (Domestic) 14.2
Turnover Rate 15.9
Median Market
Capitalization
$37,094.78 Million
10 Largest Holdings
Represents 34.27 % of Total Net Assets
View Holdings as of:
AbbVie
Aetna
Alexion Pharmaceuticals
Allergan
Cigna
Gilead Sciences
Humana
McKesson
UnitedHealth Group
Valeant Pharmaceuticals International
As of 07/31/2015 the Health Sciences Fund had a total of 159 holdings.
Sector Diversification
as of 07/31/2015
% of Total Net Assets
Biotechnology 31.5%
Services 28.6%
Pharmaceuticals 21.2%
Products & Devices 9.6%
Life Sciences 4.6%
See Glossary for additional details on all data elements.